State Street Corporation 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:52 am Sale |
2023-12-31 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
1,062,951 2.050% |
-69,004 (-6.10%) |
Filing |
| 2023-10-10 11:27 am Sale |
2023-09-30 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
1,131,955 2.180% |
-4,686,000 (-80.54%) |
Filing |
| 2023-01-10 08:13 am Purchase |
2022-12-31 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
5,817,955 11.660% |
2,785,228 (+91.84%) |
Filing |
| 2022-02-10 1:58 pm Purchase |
2021-12-31 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
3,032,727 5.640% |
3,032,727 (New Position) |
Filing |